Daniela Trabattoni1, Paolo M Ravagnani1, Luca Merlino1, Piero Montorsi1,2, Antonio L Bartorelli1,3. 1. Centro Cardiologico Monzino, IRCCS Milan, Italy. 2. Department of Clinical Sciences and Community Health, University of Milan Italy. 3. Department of Biomedical and Clinical Sciences, "Luigi Sacco", University of Milan Milan, Italy.
Abstract
BACKGROUND: The COVID-19 outbreak harmed acute coronary syndromes. During the national lockdown in Italy, the fear of post-admission contagion translated into significant delays in seeking medical help among STEMI (ST-elevation myocardial infarction) patients. OBJECTIVE AND METHODS: Our analysis aimed to assess the ACS (Acute Coronary Syndromes) admissions during the pandemic, together with time to presentation and clinical outcomes compared to 2019 in a cardiovascular hub in Milan. Data of ACS patients admitted during the pandemic year 2020 were extracted by the hospital's database and compared to a historical cohort of patients admitted for the same clinical indications in 2019. RESULTS: A total of 599 ACS cases were recorded in 2020 vs. 386 cases in 2019, with a net 55% increase, associated with late clinical presentations, a threefold increase in cardiogenic shock, and a more than two-fold higher mortality rate. CONCLUSIONS: The ultimate goal of this analysis is to preserve the life-saving focus on universal and prompt STEMI diagnosis and treatment, even in a time of dynamic global crisis. AJCD
BACKGROUND: The COVID-19 outbreak harmed acute coronary syndromes. During the national lockdown in Italy, the fear of post-admission contagion translated into significant delays in seeking medical help among STEMI (ST-elevation myocardial infarction) patients. OBJECTIVE AND METHODS: Our analysis aimed to assess the ACS (Acute Coronary Syndromes) admissions during the pandemic, together with time to presentation and clinical outcomes compared to 2019 in a cardiovascular hub in Milan. Data of ACS patients admitted during the pandemic year 2020 were extracted by the hospital's database and compared to a historical cohort of patients admitted for the same clinical indications in 2019. RESULTS: A total of 599 ACS cases were recorded in 2020 vs. 386 cases in 2019, with a net 55% increase, associated with late clinical presentations, a threefold increase in cardiogenic shock, and a more than two-fold higher mortality rate. CONCLUSIONS: The ultimate goal of this analysis is to preserve the life-saving focus on universal and prompt STEMI diagnosis and treatment, even in a time of dynamic global crisis. AJCD
Authors: Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Paul C Evans; G Ed Rainger; Justin C Mason; Tomasz J Guzik; Elena Osto; Zania Stamataki; Desley Neil; Imo E Hoefer; Maria Fragiadaki; Johannes Waltenberger; Christian Weber; Marie-Luce Bochaton-Piallat; Magnus Bäck Journal: Cardiovasc Res Date: 2020-12-01 Impact factor: 13.081
Authors: Jianhua Wu; Mamas A Mamas; Mohamed O Mohamed; Chun Shing Kwok; Chris Roebuck; Ben Humberstone; Tom Denwood; Thomas Luescher; Mark A de Belder; John E Deanfield; Chris P Gale Journal: Heart Date: 2020-09-28 Impact factor: 5.994